2 results
Approved WMOCompleted
To investigate the safety, tolerability and pharmacokinetics after multiple daily doses of YTX-7739
Approved WMOCompleted
The primary efficacy endpoint is treatment success in the therapy for mild to moderate Crohn*s disease with fisultas defined by: - A reduction of at least 50% in the number of draining fistulas at both week 4 and week 8